What Is Novel in Benefit/Risk of Bio-Absorbable Stent Compared to Other DES– US Academia’s View - Ron Waksman, MD

Target Audience

• Interventional Cardiologists
• Clinical Trial Investigators
• Medical Device Professionals

Session Name: Session IV: Bio-Absorbable Stent

Track: Technology & Innovation

Learning Objectives

• Updates on regulatory harmonisation and clinical trial design in the US & Japan

Other Components in this Moment